⌘K

Login Start Free

Home/Filings/4/0001288952-25-000004

4//SEC Filing

SCHMERTZLER MICHAEL 4

Accession 0001288952-25-000004

CIK 0001070081other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:20 PM ET

Size

6.8 KB

Accession

0001288952-25-000004

Insider Transaction Report

Form 4

Period: 2025-12-16

PTC THERAPEUTICS, INC.PTCT

SCHMERTZLER MICHAEL

Director

Transactions

Exercise/Conversion
Common Stock
2025-12-16$30.86/sh+24,000$740,640→ 155,266 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-16−24,000→ 0 total
Exercise: $30.86Exp: 2026-01-03→ Common Stock (24,000 underlying)

Footnotes (1)

[F1]Currently exercisable.

Documents

1 file

4
form4-12182025_051201.xmlPrimary

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1

filerCIK 0001288952

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 5:20 PM ET
Size: 6.8 KB

View on SEC.gov